Ever wondered what it takes to invest in the cutting-edge of biotech? In this episode, we sit down with Yaniv Sneor, a serial entrepreneur turned life science angel investor, to explore the world of early-stage biotech investing.
From founding and scaling companies to building a niche angel investment group, Yaniv shares insights on:
The differences between public market investing vs. angel investing in biotech
How his group conducts rigorous due diligence on transformative companies
Key qualities and metrics he looks for in founders and startups
Strategies for accredited investors to navigate the life sciences landscape
The potential for high returns and why early-stage investments matter
Whether you’re an investor, entrepreneur, or just curious about the intersection of science and finance, this episode gives a rare, insider look at how angels identify and support the next generation of breakthrough therapies and devices.